{"entity":{"type":"insider","cik":"0002095697","url":"/insider/0002095697","json_url":"/insider/0002095697.json","name":"Innovative Cellular Therapeutics Holdings Ltd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2,"n_filings":2,"first":"2026-07-17","last":"2026-07-20","span_basis":"filed_date"},"name_variants":[{"name":"Innovative Cellular Therapeutics Holdings Ltd","source":"filing","n_filings":2,"first_seen":"2026-07-17","last_seen":"2026-07-20"}],"transactions":[{"id":5883373,"accession":"0001140361-26-028955","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-26-028955","line_url":"/filing/0001140361-26-028955#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0002095697","owner_name":"Innovative Cellular Therapeutics Holdings Ltd","owner_display_name":"Innovative Cellular Therapeutics Holdings Ltd","owner_url":"/insider/0002095697","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10.0,"shares_display":"10","price_per_share":13.7,"price_display":"13.70","price_state":"stated","total_value":137.0,"total_display":"137.00","total_whole":"137","shares_owned_after":2857480.0,"shares_owned_after_display":"2,857,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-17","filed_date":"2026-07-20","scope":"insider"},{"id":5957557,"accession":"0001140361-26-028846","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-26-028846","line_url":"/filing/0001140361-26-028846#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0002095697","owner_name":"Innovative Cellular Therapeutics Holdings Ltd","owner_display_name":"Innovative Cellular Therapeutics Holdings Ltd","owner_url":"/insider/0002095697","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10.0,"shares_display":"10","price_per_share":13.73,"price_display":"13.73","price_state":"stated","total_value":137.3,"total_display":"137.30","total_whole":"137","shares_owned_after":2857490.0,"shares_owned_after_display":"2,857,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-16","filed_date":"2026-07-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":2,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001806952","name":"Lyell Immunopharma, Inc.","url":"/issuer/0001806952","role":"Ten percent owner","n_filings":2,"first_seen":"2026-07-17","last_seen":"2026-07-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002095697","retrieved_at":"2026-08-22T19:55:48+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}